For patients experiencing an ST-Elevation Myocardial Infarction (STEMI), the medical term for a heart attack, time is muscle.
“When a clot closes the coronary artery, the heart muscle starts dying, and patients can experience chest pain and other symptoms,” said Mauricio Cohen, M.D., professor of medicine and director of the Cardiac Catheterization Laboratory at the University of Miami Miller School of Medicine. “They need to be treated promptly because the longer you take to treat the patient with a heart attack, the more muscle is dying.”
Scientists, physicians and countless patients mourn the passing of Daniel H. Mintz, M.D., emeritus professor of medicine at the University of Miami Miller School of Medicine and scientific director emeritus of the Diabetes Research Institute.
A team of immunology researchers at the University of Miami Miller School of Medicine has uncovered a mechanism of immune protection for the RTS,S/AS01 malaria vaccine that could lead to an effective malaria vaccination program for children.
For COVID-19 patients in severe respiratory distress, the University of Miami Miller School of Medicine now offers access to mesenchymal stem cell (MSC) treatments that may help fight the characteristic inflammation that accompanies the viral infection.
A new initiative by infectious disease experts and researchers with the University of Miami Health System offers convalescent plasma with COVID-19 antibodies as a treatment for patients who are seriously ill from the coronavirus infection or at serious risk of progression.
The AIDS Healthcare Foundation Global Public Health Institute at the University of Miami has awarded José Szapocznik, Ph.D., chair emeritus of the Miller School of Medicine’s Department of Public Health Sciences, a grant to develop a project to promote global health protection against the spread of infectious diseases.